Skip to content

A randomized controlled study on the treatment of knee osteoarthritis with Fu's subcutaneous needling

A study on the common techniques and methods of TCM technical intervention measures specification and efficacy evaluation with floating needle technique as an example

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000033962
Enrollment
Unknown
Registered
2020-06-19
Start date
2020-06-16
Completion date
Unknown
Last updated
2020-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee osteoarthritis

Interventions

High skill Fu's subcutaneous needling:treatment conducted by high skill Fu's subcutaneous needing
Primary skill Fu's subcutaneous needing:treatment conducted by primary skill Fu's subcutaneous needing
Blank control group:Treatment was resumed 7 days after enrollment

Sponsors

Guangdong Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Those who meet the diagnostic criteria for knee osteoarthritis (2) The X-ray grade of the knee is kellgren-Lawrence I-III; (3) Persons between 45 and 75 years old.

Exclusion criteria

Exclusion criteria: (1) Acute local inflammatory reaction of the affected knee, with symptoms of redness, swelling, heat and pain; (2) Severe deformity of knee joint and malformation of lower limb; (3) Patients with serious life-threatening diseases such as cardiovascular and cerebrovascular diseases, liver, kidney and hematopoietic systems; Persons suffering from acute infectious diseases or serious skin diseases and unfit for treatment; (4) Other joint diseases: gout arthritis; Rheumatoid arthritis; Patellar malacia; Kashin-beck disease; Osteonecrosis of knee joint; Knee joint development malformation, etc.; (5) Complications affecting the joints, such as psoriasis, plum toxic neuropathy, brown yellow disease, metabolic bone disease, acute trauma, etc.; (6) Patients with malignant tumors or mental diseases; Difficult to follow visitors; (7) Target knee has a history of surgery or severe trauma in the past 1 year; (8) Patients with spontaneous bleeding tendency, such as taking anticoagulants; (9) Pregnant and lactating women; (10) Those who refuse to sign informed consent.

Design outcomes

Primary

MeasureTime frame
WOMAC;WOMAC;

Secondary

MeasureTime frame
Immediate pain improvement;Security indicators;Immediate pain improvement;Security indicators;

Countries

China

Contacts

Public ContactHongjiao Li

Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences;Wangjing Hospital, China Academy of Chinese Medical Sciences

lhjiao2013@163.com+86 15011003216

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026